Iris Kamer

4.9k total citations
31 papers, 1.9k citations indexed

About

Iris Kamer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Iris Kamer has authored 31 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Iris Kamer's work include Cancer Immunotherapy and Biomarkers (9 papers), Cancer-related Molecular Pathways (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Iris Kamer is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Cancer-related Molecular Pathways (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Iris Kamer collaborates with scholars based in Israel, United States and France. Iris Kamer's co-authors include Ayelet Chajut, Andrei V. Budanov, Elena Feinstein, Elena Zelin, Alexander Faerman, Paz Einat, Svetlana Gorodin, Hagar Kalinski, Rami Skaliter and Tzipora Shoshani and has published in prestigious journals such as Cell, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Iris Kamer

31 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iris Kamer Israel 17 1.2k 670 474 294 276 31 1.9k
Daniel J. Murphy United Kingdom 22 2.2k 1.8× 843 1.3× 645 1.4× 317 1.1× 306 1.1× 43 3.0k
Kimberley Evason United States 22 1.0k 0.9× 886 1.3× 570 1.2× 241 0.8× 209 0.8× 42 2.9k
Alexander Valent France 18 962 0.8× 659 1.0× 572 1.2× 271 0.9× 294 1.1× 41 1.9k
Jayashree Karar United States 15 946 0.8× 299 0.4× 459 1.0× 179 0.6× 266 1.0× 19 1.8k
Xiaoping Zhao China 32 1.8k 1.6× 500 0.7× 1.2k 2.6× 226 0.8× 189 0.7× 84 2.8k
Maria Nesterova United States 30 1.5k 1.3× 669 1.0× 420 0.9× 165 0.6× 271 1.0× 71 2.8k
Brian M. Necela United States 24 1.1k 0.9× 691 1.0× 592 1.2× 366 1.2× 147 0.5× 52 2.2k
William Matthews United States 22 1.3k 1.1× 418 0.6× 362 0.8× 459 1.6× 191 0.7× 37 3.1k
Dietmar Abraham Austria 24 1.1k 1.0× 584 0.9× 319 0.7× 580 2.0× 272 1.0× 77 2.3k
Giuseppe Raschellà Italy 29 1.8k 1.5× 681 1.0× 660 1.4× 165 0.6× 178 0.6× 68 2.7k

Countries citing papers authored by Iris Kamer

Since Specialization
Citations

This map shows the geographic impact of Iris Kamer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Kamer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Kamer more than expected).

Fields of papers citing papers by Iris Kamer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Kamer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Kamer. The network helps show where Iris Kamer may publish in the future.

Co-authorship network of co-authors of Iris Kamer

This figure shows the co-authorship network connecting the top 25 collaborators of Iris Kamer. A scholar is included among the top collaborators of Iris Kamer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris Kamer. Iris Kamer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eisenberg, Vasyl, Iris Kamer, Jair Bar, et al.. (2024). Targeting Tumor-Associated Sialic Acids Using Chimeric Switch Receptors Based on Siglec-9 Enhances the Antitumor Efficacy of Engineered T Cells. Cancer Immunology Research. 12(10). 1380–1391. 3 indexed citations
2.
Shaked, Yuval, Madeleine Benguigui, Ruth Halaban, et al.. (2023). A subset of neutrophils as a predictive biomarker for immunotherapy response in patients with non–small-cell lung cancer and melanoma.. Journal of Clinical Oncology. 41(16_suppl). 2557–2557. 1 indexed citations
3.
Wiesel, Ory, Sook Whan Sung, Amit Katz, et al.. (2023). A Novel Urine Test Biosensor Platform for Early Lung Cancer Detection. Biosensors. 13(6). 627–627. 7 indexed citations
4.
Haberman, Yael, Iris Kamer, Amnon Amir, et al.. (2023). Gut microbial signature in lung cancer patients highlights specific taxa as predictors for durable clinical benefit. Scientific Reports. 13(1). 2007–2007. 12 indexed citations
5.
Cohen, Merav, Amir Giladi, Oren Barboy, et al.. (2022). The interaction of CD4+ helper T cells with dendritic cells shapes the tumor microenvironment and immune checkpoint blockade response. Nature Cancer. 3(3). 303–317. 117 indexed citations
6.
Peled, Michael, Jair Bar, Iris Kamer, et al.. (2021). Mesencephalic astrocyte-derived neurotrophic factor is secreted from interferon-γ–activated tumor cells through ER calcium depletion. PLoS ONE. 16(4). e0250178–e0250178. 5 indexed citations
7.
Kamer, Iris, Elizabeta Bab-Dinitz, Gili Perry, et al.. (2020). Stromal-MDM2 Promotes Lung Cancer Cell Invasion through Tumor–Host Feedback Signaling. Molecular Cancer Research. 18(6). 926–937. 9 indexed citations
8.
Kamer, Iris, Yael Steuerman, Gili Perry, et al.. (2020). Predicting brain metastasis in early stage non-small cell lung cancer patients by gene expression profiling. Translational Lung Cancer Research. 9(3). 682–692. 22 indexed citations
9.
Bar, Jair, Efrat Ofek, Iris Barshack, et al.. (2019). Transformation to small cell lung cancer as a mechanism of resistance to immunotherapy in non-small cell lung cancer. Lung Cancer. 138. 109–115. 44 indexed citations
10.
Bar, Jair, et al.. (2017). Investigating of Immunotherapy and Combination Treatments in Ex-Vivo Culture Model of NSCLC. Journal of Thoracic Oncology. 12(8). S1538–S1538. 1 indexed citations
11.
Lerrer, Shalom, Yulia Liubomirski, Leonor Leider–Trejo, et al.. (2015). Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway. Stem Cell Research & Therapy. 6(1). 87–87. 109 indexed citations
12.
Madar, Shalom, Ido Goldstein, Yan Stein, et al.. (2013). Mutant p53 Attenuates the Anti-Tumorigenic Activity of Fibroblasts-Secreted Interferon Beta. PLoS ONE. 8(4). e61353–e61353. 36 indexed citations
13.
Madar, Shalom, Ira Kogan-Sakin, Iris Kamer, et al.. (2011). TMPRSS2/ERG Promotes Epithelial to Mesenchymal Transition through the ZEB1/ZEB2 Axis in a Prostate Cancer Model. PLoS ONE. 6(7). e21650–e21650. 90 indexed citations
14.
Kogan-Sakin, Ira, Yuval Tabach, Alina Molchadsky, et al.. (2010). Mutant p53R175H upregulates Twist1 expression and promotes epithelial–mesenchymal transition in immortalized prostate cells. Cell Death and Differentiation. 18(2). 271–281. 130 indexed citations
15.
Paland, Nicole, Iris Kamer, Ira Kogan-Sakin, et al.. (2009). Differential Influence of Normal and Cancer-Associated Fibroblasts on the Growth of Human Epithelial Cells in an In vitro Cocultivation Model of Prostate Cancer. Molecular Cancer Research. 7(8). 1212–1223. 56 indexed citations
16.
Kamer, Iris, Rachel Sarig, Yehudit Zaltsman, et al.. (2005). Proapoptotic BID Is an ATM Effector in the DNA-Damage Response. Cell. 122(4). 593–603. 178 indexed citations
17.
Kamer, Iris, Jacob Douek, Moshe Tom, & Baruch Rinkevich. (2003). Metallothionein Induction in the RTH-149 Cell Line as an Indicator for Heavy Metal Bioavailability in a Brackish Environment: Assessment by RT-Competitive PCR. Archives of Environmental Contamination and Toxicology. 45(1). 86–91. 19 indexed citations
18.
Shoshani, Tzipora, Alexander Faerman, Igor Mett, et al.. (2002). Identification of a Novel Hypoxia-Inducible Factor 1-Responsive Gene, RTP801 , Involved in Apoptosis. Molecular and Cellular Biology. 22(7). 2283–2293. 479 indexed citations
19.
Budanov, Andrei V., Tzipora Shoshani, Alexander Faerman, et al.. (2002). Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability. Oncogene. 21(39). 6017–6031. 315 indexed citations
20.
Kamer, Iris & Baruch Rinkevich. (2002). In vitro application of the comet assay for aquatic genotoxicity: considering a primary culture versus a cell line. Toxicology in Vitro. 16(2). 177–184. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel J. Murphy Breakdown of academic impact, for papers by Kimberley Evason Breakdown of academic impact, for papers by Alexander Valent Breakdown of academic impact, for papers by Jayashree Karar Breakdown of academic impact, for papers by Xiaoping Zhao Breakdown of academic impact, for papers by Maria Nesterova Breakdown of academic impact, for papers by Brian M. Necela Breakdown of academic impact, for papers by William Matthews Breakdown of academic impact, for papers by Dietmar Abraham Breakdown of academic impact, for papers by Giuseppe Raschellà
Rankless by CCL
2026